Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

M&S orders factory workers to stay home as cyberattack recovery continues

(Sharecast News) - Marks & Spencer has told around 200 workers at its Castle Donington logistics site to not come into work as the retailer continues to recover from a cyberattack. M&S, which is currently not taking online orders as it grapples with the fallout from what it called a "cyber incident", is said to have ordered agency workers at the East Midlands logistics centre to stay home, according to Sky News.

Agency workers are thought to make up around 20% of the workforce at the Caste Donington site, which handles the retailer's clothing and homewares products.

Other employees at the centre, however, have been told to continue working as usual.

On Wednesday, M&S said it had moved some of its processes offline following a cyberattack "to protect our colleagues, partners, suppliers and our business".

The company had paused click-and-collect orders and stopped taking contactless payments, before suspending online orders completely on Friday.

On Monday, when trying to place an order on the M&S website, shoppers are faced with the following notice: "Products remain available to browse online and stores are open."

M&S shares were down 2.3% at 377p by 1213 GMT, having dropped around 8% over the past week.

Share this article

Related Sharecast Articles

RBC Capital ups price target on Hikma
(Sharecast News) - RBC Capital Markets has upped both forecasts and its price target for blue chip generics specialist Hikma Pharmaceuticals.
Home Depot won't hike prices in response to tariffs, Q1 sales fall
(Sharecast News) - US do-it-yourself chain Home Depot on Tuesday held full-year sales forecasts and said it did not expect to raise prices in response to President Donald trump's tariffs.
Poolbeg raises nearly £5m to progress clinical trials
(Sharecast News) - Shares in biopharmaceutical group Poolbeg Pharma sank on Tuesday after the company revealed wider losses for the 2024 financial year as it raised nearly £5m in an oversubscribed placing as it progresses two key clinical trials.
Berenberg starts coverage of Accesso Technology at 'buy'
(Sharecast News) - Berenberg initiated coverage of Accesso Technology on Tuesday with a 'buy' rating and 775p price target.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.